申请人:BioEnergenix
公开号:US20140235579A1
公开(公告)日:2014-08-21
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
本文披露了新的杂环化合物及其组合物,并将其应用于治疗疾病的药物。还提供了抑制人类或动物主体中PAS激酶(PASK)活性的方法,用于治疗糖尿病等疾病。